Neurocrine Biosciences Inc. Equity-NMS: NBIX

Healthcare

Drug Manufacturers - Specialty & Generic

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Previous close :$130.4
Open :$131.65
Today's high :$132.64
Today's low :$129.15
52W low :$89.04
52W high :$143.35
1Y :29.92%
5Y :65.14%
EPS(TTM): :2.47
Shares O/S :99.51 M
Market cap :13.07 B

Compare with Other Stocks

Frequently Asked Questions

What is the share price of Neurocrine Biosciences Inc. today?

Neurocrine Biosciences Inc. (NBIX) share price as of March 3, 2024, is $131.3. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Neurocrine Biosciences Inc.?

Yes, Indian Investors can invest in the Neurocrine Biosciences Inc. (NBIX) Share by opening an international trading account with Angel One.

How can I purchase Neurocrine Biosciences Inc. shares in India?

Purchasing Neurocrine Biosciences Inc. (NBIX) share from India can be done by:
  1. Directly: By opening an international trading account with Angel One. The process would include KYC verification.
    The account activation takes a few minutes to a few hours, after which you can start buying Neurocrine Biosciences Inc. (NBIX) by making deposits in US dollars.
  2. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Neurocrine Biosciences Inc.?

Yes, you can purchase fractional shares of Neurocrine Biosciences Inc. (NBIX) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Neurocrine Biosciences Inc.?

The market capitalization of Neurocrine Biosciences Inc. on March 3, 2024, is $13.07 B.

In which sector Neurocrine Biosciences Inc. belongs?

Neurocrine Biosciences Inc. operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.

What documents are required to invest in Neurocrine Biosciences Inc. stocks?

In order to invest in Neurocrine Biosciences Inc. (NBIX) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

About Neurocrine Biosciences Inc.

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company. The Company is engaged in discovering and developing treatments for patients with under-addressed neurological, neuroendocrine and neuropsychiatric disorders. Its diverse portfolio includes the United States Food and Drug Administration-approved treatments for tardive dyskinesia, chorea associated with Huntington’s disease, endometriosis and uterine fibroids, as well as a robust pipeline, including multiple compounds in mid-to late-phase clinical development across its core therapeutic areas. Its commercial products include INGREZZA, ALKINDI, EFMODY, Orilissa and Oriahnn. INGREZZA is marketed as DYSVAL (valbenazine) in Japan and REMLEAS (valbenazine) in other select Asian markets, where Mitsubishi Tanabe Pharma Corporation retains commercialization rights. ALKINDI is marketed as ALKINDI SPRINKLE (hydrocortisone) in the United States, where Eton Pharmaceuticals, Inc. retains commercialization rights.